Adel M. Aljadaan

Dr. Adel M. Aljadaan

Clinical Pharmacology and Toxicology, Najran University, Najrān, Saudi Arabia
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2022 in Saudi Pharmaceutical Journal
Verified
Journal Article
Open access
AAAli Alshabi
Ali Alshabi
MSMohammed Ashique K. Shaikh
Mohammed Ashique K. Shaikh
ISIbrahim Ahmed Shaikh
Ibrahim Ahmed Shaikh
SASaad Ahmed Alkahtani
Saad Ahmed Alkahtani
Adel M. AljadaanAdel M. Aljadaan
Adel M. Aljadaan
Pharmacovigilance (PV) is critical in determining the risk–benefit ratio of medicines and encouraging their safe, rational, and effective use, hence enhancing patient safety and care. Pharmacists, as drug experts, share responsibility for ensuring that medicines remain safe. The study aimed to assess the knowledge, attitude, and practice of hospital pharmacists towards PV and adverse drug reaction (ADR) reporting and to know factors that discourage them from reporting ADRs in Najran, Saudi Arabia. A pre-tested self-administered questionnaire was distributed to all the pharmacists working in government hospitals who consented to participate in the study. Data was collected over three months, from 01 June 2018 to 31 Aug 2018. Data were analyzed using Statistical Package for Social Science (SPSS) software for Windows, version 23. Descriptive statistics such as frequency and percentages, mean ± standard deviation (SD) were calculated, and the Pearson's Chi-square test was used to examine the relationship between different variables. A total of 145 questionnaires were distributed, and the response rate obtained was 70.3%. The definition of PV and ADR were correctly identified by 42% and 68.3% of participants, respectively. A noteworthy finding is that 95% of participants were aware of the existence of the ADR reporting system, and 88.9% knew the responsible regulatory agency. Participants showed a positive attitude towards PV and ADR reporting; 90.1% considered ADR reporting a part of professional obligation, and 94.1% believed that there should be collaboration between pharmacists and other healthcare professionals. A majority of participants (86.1%) had identified an ADR during their practice, and 71.3% had reported an ADR. The unavailability of a professional environment to discuss ADR and insufficient pharmacotherapy/clinical knowledge was cited as the main factors discouraging from reporting ADRs. Overall, the pharmacists had an average to good knowledge of and positive attitude towards PV and ADR reporting and a good ADR reporting practice. The concept of PV and ADR reporting should be further strengthened, and there is a vast potential for the same.

27 December 2023 in Frontiers in Public Health
Verified
Journal Article
Open access
MAMd Habban Akhter
Md Habban Akhter
LALamya Ahmad Al-Keridis
Lamya Ahmad Al-Keridis
MSMohd Saeed
Mohd Saeed
HKHabibullah Khalilullah
Habibullah Khalilullah
SRSafia Obaidur Rab
Safia Obaidur Rab
OAObaid Afzal
Obaid Afzal
Berberine–encapsulated polyelectrolyte nanocomposite (BR–PolyET–NC) gel was developed as a long-acting improved wound healing therapy. BR–PolyET–NC was developed using an ionic gelation/complexation method and thereafter loaded into Carbopol gel. Formulation was optimized using Design-Expert® software implementing a three-level, three-factor Box Behnken design (BBD). The concentrations of polymers, namely, chitosan and alginate, and calcium chloride were investigated based on particle size and %EE. Moreover, formulation characterized in vitro for biopharmaceutical performances and their wound healing potency was evaluated in vivo in adult BALB/c mice. The particle distribution analysis showed a nanocomposite size of 71 ± 3.5 nm, polydispersity index (PDI) of 0.45, ζ–potential of +22 mV, BR entrapment of 91 ± 1.6%, and loading efficiency of 12.5 ± 0.91%. Percentage drug release was recorded as 89.50 ± 6.9% with pH 6.8, thereby simulating the wound microenvironment. The in vitro investigation of the nanocomposite gel revealed uniform consistency, well spreadability, and extrudability, which are ideal for topical wound use. The analytical estimation executed using FT-IR, DSC, and X-ray diffraction (XRD) indicated successful formulation with no drug excipients and without the amorphous state. The colony count of microbes was greatly reduced in the BR–PolyET–NC treated group on the 15th day from up to 6 CFU compared to 20 CFU observed in the BR gel treated group. The numbers of monocytes and lymphocytes counts were significantly reduced following healing progression, which reached to a peak level and vanished on the 15th day. The observed experimental characterization and in vivo study indicated the effectiveness of the developed BR–PolyET–NC gel toward wound closure and healing process, and it was found that >99% of the wound closed by 15th day, stimulated via various anti-inflammatory and angiogenic factors.

1 December 2021 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
Basel A Abdel-WahabBasel A Abdel-Wahab
Basel A Abdel-Wahab
HAHussain Alqhtani
Hussain Alqhtani
IWIsmail A. Walbi
Ismail A. Walbi
HAHassan A. Albarqi
Hassan A. Albarqi
Adel M. AljadaanAdel M. Aljadaan
Adel M. Aljadaan
EHEmad H.M. Hassanein
Emad H.M. Hassanein

1 January 2025 in Critical Reviews™ in Therapeutic Drug Carrier Systems
Verified
Journal Article
Closed access
PDF file
KSKangkan Sarma
Kangkan Sarma
MAMd Habban Akhter
Md Habban Akhter
AAAmnah Alalmaie
Amnah Alalmaie
IAIrfan Ahmad
Irfan Ahmad
MAMohd Nazam Ansari
Mohd Nazam Ansari
Adel M. AljadaanAdel M. Aljadaan
Adel M. Aljadaan
Lung cancer has the second highest occurrence and lowest survival rate among all cancers and incidence rates are increasing. From the tumor milieu, tumors exude chemokines and cytokines that hassle the pulmonary drug administration hinders the success of treatment. A few mutations lead to generation of lungs cancer. It has prominent levels of mutated genes such as TP53, KRAS, MET, and EGFR. Various molecular pathways involved in causing lung cancer such as PTEN/PI3K/AKT pathway, JAK/STAT pathways, RAF-MEK-ERK, PI3K-AKT-mTOR, and RALGDS-RA, PI3K, AKT, and PI3K/AKT/mTOR pathway. Inhibition of such biological pathway through active targeting, using various biological inhibitors, and blockers could help in treating and recurrence of lungs tumor. The conventional therapeutic modalities concomitant with personalized genomic nanomedicine can have potential in improving treatment regimen. This study explored the different genomic changes that occur due to the prime etiological factors, their reported treatment profile, and nanocarrier mediated therapeutic strategy by targeting tumor microenvironment (TME). Nanocarriers confront multiple obstacles in their journey to the TME therapeutic approach as leaky vasculature, large fenestration, and usually carried off from immune system and phagocytosis process. However, formulators designed a bio-functionalized carrier that enable to evade opsonization, escape immune system, modulate TME, identify reticuloendothelial system, and thus facilitates biological interaction, and enhance cellular uptake.

3 September 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
Adel M. AljadaanAdel M. Aljadaan
Adel M. Aljadaan
AAAyman M. AlSaadi
Ayman M. AlSaadi
Ibrahim Ahmed ShaikhIbrahim Ahmed Shaikh
Ibrahim Ahmed Shaikh
AWAlison Whitby
Alison Whitby
ARArundhati Ray
Arundhati Ray
Wayne CarterWayne Carter
Wayne Carter
Background/Objectives: Alzheimer’s disease (AD) is the most prevalent form of dementia and is characterized by a decline in cognition that may be due, in part, to deficient cholinergic signalling. Cholinesterase inhibitors (ChEIs) are the first-line pharmacotherapies for treating the diminished cholinergic function in AD patients. Plant phytochemicals may provide useful ChEIs and mitigate other elements of AD pathology, including oxidative stress. Methods: Herein, the phytochemicals present in Moringa oleifera aqueous and methanolic extracts were identified by LC-MS/MS and the potential of several phytochemicals (4-O-caffeoylquinic acid (4-CQA), quercetin 3-β-D-glucoside (Q3-β-D), chlorogenic acid (CGA), and rutin) to act as ChEIs and antioxidants was assessed. Results: The phytochemicals inhibited human acetylcholinesterase (AChE) in the following order of potency: 4-CQA > Q3-β-D > CGA > rutin; for AChE from Electrophorus electricus, the order of potency was Q3-β-D > 4-CQA > CGA > rutin. For human butyrylcholinesterase (hBuChE), the order of potency was rutin > 4-CQA > Q3-β-D > CGA and for equine serum BuChE, it was 4-CQA > Q3-β-D > rutin > CGA. Molecular docking validated the binding of the phytochemicals to cholinesterases, with binding affinities comparable to or higher than those of ChEI drugs. All the phytochemicals displayed potent radical-scavenging and antioxidant activities across six assays. 4-CQA was the most effective antioxidant in three of the assays. Conclusions: M. oleifera contains phytochemicals with weak ChEI activity and potent antioxidant capacity, with potential use as nutraceuticals to treat the cholinergic signalling deficit and oxidative stress that typifies AD pathology.

7 December 2024 in Chemical Papers
Verified
Journal Article
Closed access
PDF file
ISIbrahim Ahmed Shaikh
Ibrahim Ahmed Shaikh
VHVeeranna S Hombalimath
Veeranna S Hombalimath
SBShrikanth Kalappa Badiger
Shrikanth Kalappa Badiger
SGSayeed Aaqueeb M. Gaddi
Sayeed Aaqueeb M. Gaddi
MMMater H. Mahnashi
Mater H. Mahnashi
SISyed Mohammad Shakeel Iqubal
Syed Mohammad Shakeel Iqubal